Advancing stem cell therapy with biodegradable scaffoldAllbiopro2018-11-07T08:37:48+09:0011월 7th, 2018|
Clearside Biomedical Shares Plunge as Phase III Xipere Failure Forces the Company to Discontinue StudyAllbiopro2018-11-06T10:27:44+09:0011월 6th, 2018|
Takeda Licenses Oncology Target from Crescendo BiologicsAllbiopro2018-11-06T10:27:14+09:0011월 6th, 2018|
Eli Lilly’s Diabetes Drug Trulicity Reduces the Risk of Heart Attack and StrokeAllbiopro2018-11-06T10:26:46+09:0011월 6th, 2018|
FDA Gives Pfizer’s Lorbrena Thumbs-up for ALK Mutation Lung CancerAllbiopro2018-11-06T10:25:51+09:0011월 6th, 2018|
Sage Therapeutics Could Snag the First FDA-Approved PPD Drug with ZulressoAllbiopro2018-11-06T10:25:24+09:0011월 6th, 2018|
Novartis Plans for 60 Regulatory Filings Over the Next Three YearsAllbiopro2018-11-06T10:24:56+09:0011월 6th, 2018|
FDA Commissioner Outlines Reasons Why a Powerful Opioid Pain Treatment Was ApprovedAllbiopro2018-11-06T10:24:01+09:0011월 6th, 2018|
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ OptionAllbiopro2018-11-06T10:23:32+09:0011월 6th, 2018|
Novartis’ Sandoz calls it quits on Rituxan biosimilar after FDA requests more dataAllbiopro2018-11-06T10:23:01+09:0011월 6th, 2018|
Goodbye to Lyrica ads? Big TV spender drops off top 10 list in OctoberAllbiopro2018-11-06T10:22:31+09:0011월 6th, 2018|
AcelRx’s controversial under-the-tongue opioid nod sparks rare defense from FDA chiefAllbiopro2018-11-06T10:22:03+09:0011월 6th, 2018|
Coherus’ newly minted Neulasta biosim steps up pressure on AmgenAllbiopro2018-11-06T10:21:33+09:0011월 6th, 2018|
